Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

NCT00980018

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
  • USC Norris Cancer Center LAC & USC Medical Center Los Angeles, California, United States
  • Southwest Cancer Care Murrieta Poway, California, United States
View all 23 locations
View Trial Details
Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

NCT00109707

Conditions
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
View all 101 locations
View Trial Details
Completed

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

NCT00171158

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +18 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Faber Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Poitiers, France
View Trial Details
Completed

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

NCT01433445

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Magdeburg, Germany
  • Novartis Investigative Site Mainz, Germany
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details
Completed

French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia

NCT01192347

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • GH Pitie Salpetriere Paris, Cedex 13, France
  • CH DU Pays D Aix Aix-en-Provence, Cedex 1, France
  • Hopital Dupuytren Limoges, Cedex 1, France
  • Hopital Emile Muller Mulhouse, Cedex 1, France
View all 46 locations
View Trial Details

Related conditions